These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry. Nabbout R; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; O'Callaghan F; Qin J; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC; Kingswood JC Front Neurol; 2021; 12():697467. PubMed ID: 34566842 [No Abstract] [Full Text] [Related]
7. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex. van der Poest Clement EA; Sahin M; Peters JM J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739 [TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of treatments for infantile spasms. Nabbout R Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869 [TBL] [Abstract][Full Text] [Related]
9. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. Hancock E; Osborne JP J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425 [TBL] [Abstract][Full Text] [Related]
10. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex. Whitney R; Jan S; Zak M; McCoy B Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505 [TBL] [Abstract][Full Text] [Related]
11. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640 [TBL] [Abstract][Full Text] [Related]
12. Could prevention of infantile spasms have been possible in a historical cohort of 31 tuberous sclerosis patients? Riikonen R Eur J Paediatr Neurol; 2021 Nov; 35():153-157. PubMed ID: 34731702 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of vigabatrin for the treatment of infantile spasms. Faulkner MA; Tolman JA J Cent Nerv Syst Dis; 2011; 3():199-207. PubMed ID: 23861649 [TBL] [Abstract][Full Text] [Related]
14. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043 [TBL] [Abstract][Full Text] [Related]
15. Secular changes in severity of intellectual disability in tuberous sclerosis complex: A reflection of improved identification and treatment of epileptic spasms? Tye C; Thomas LE; Sampson JR; Lewis J; O'Callaghan F; Yates JRW; Bolton PF Epilepsia Open; 2018 Jun; 3(2):276-280. PubMed ID: 29881807 [TBL] [Abstract][Full Text] [Related]
17. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563 [TBL] [Abstract][Full Text] [Related]
18. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy. Iyer A; Appleton R Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933 [TBL] [Abstract][Full Text] [Related]